Skip to content

GSK

GSK Plc

NYSE · Healthcare · Drug Manufacturers - General · GB

$50.22
−1.65%
Ask drillr

Next report

Analyst consensus

Next report date
Oct 28, 2026
EPS estimate
$1.37
Revenue estimate
$12.0B

Latest reported

Last report date
Jul 28, 2026
EPS actual
$1.36
EPS estimate
$1.26
Revenue actual
$11.2B
Revenue estimate
$11.0B

Track record

Trailing twelve quarters

EPS beats (12Q)
10
EPS misses (12Q)
1
EPS in line (12Q)
0
Avg surprise (4Q)
+9.5%
Revenue beats (12Q)
8
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Jul 28, 2026$1.26$1.36Beat 7.51%$11.2B
Apr 29, 2026$1.16$1.24Beat 6.90%$10.3B
Feb 4, 2026$0.64$0.68Beat 6.25%$8.5B
Oct 29, 2025$1.26$1.48Beat 17.46%$8.5B
Jul 30, 2025$0.96$10.9B
Apr 30, 2025$1.08$1.13Beat 4.63%$9.7B
Feb 5, 2025$0.44$0.59Beat 34.09%$10.2B
Oct 30, 2024$1.16$1.27Beat 9.48%$10.5B
Jul 31, 2024$1.00$1.09Beat 9.00%$10.0B
Jan 31, 2024$0.76$0.72Miss -5.26%$9.2B
Nov 1, 2023$1.09$1.26Beat 15.60%$10.2B
Jul 26, 2023$0.87$0.97Beat 11.49%$9.9B

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 28, 2026